Gilad Oren Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$30,343.71
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Gilad Oren

According to the SEC Form 4 filings, Gilad Oren, being in a position of

  1. President/CEO at Aprea Therapeutics, Inc.,
    оver the last 12 months, has bought 7400 shares for $15,764, and sold 0 shares,
    over all time since 2024-03-13, has bought 9400 shares for $30,344, and sold 0 shares.

The largest purchase of all time was on 2024-03-13 and amounted to 2000 shares of Aprea Therapeutics, Inc. for $14,580.

Biography of Gilad Oren

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$15,7645100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2025-04-03PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
5,500
0.1023%
$1.84$10,110-4.34%
2024-10-23PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
500
0.0086%
$3.92$1,958-14.87%
2024-10-15PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
250
0.0046%
$2.90$725+10.05%
2024-10-14PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
1,000
0.0163%
$2.59$2,590+30.86%
2024-10-10PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
150
0.0024%
$2.54$381+31.89%
2024-03-13PurchaseAprea Therapeutics, Inc.
APRE
President, CEO
2,000
0.0683%
$7.29$14,580-31.53%
Total: 6
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.